While deficiency is relatively rare in developed countries due to the availability of fresh produce and the addition of vitamin C to certain foods and supplements, it still affects roughly 7% of adults in the US ( The most common risk factors for vitamin C deficiency are poor diet, alcoholism, anorexia, severe mental illness, smoking and dialysis ( While symptoms of severe vitamin C deficiency can take months to develop, there are some subtle signs to watch out for
The key word in all of this is deficient, because that is where the benefit lives
Potential theoretical advantages include: Multi-pathway appetite suppression combining amylin and incretin signals Enhanced metabolic flexibility through glucagon receptor activation (retatrutide) and amylin-mediated effects (cagrilintide) Complementary gastric emptying effects from both compounds Broader receptor coverage addressing multiple aspects of energy homeostasis However, it's critical to emphasize: no published clinical trials have evaluated the cagrilintide dosage with retatrutide combination as of 2026
If a breastfeeding infant experiences an adverse effect related to a maternally ingested drug, healthcare providers are encouraged to report the adverse effect to the FDA
Manufactured in the United States, this peptide supports controlled research into sleep and recovery signaling pathways.